With the start of work on a new facility in Oegstgeest, the Netherlands, DuPont marked itself out as a company serious about investing in research and infrastructure to support gut health work in animals. The new site – slated to open in 2020 – is set to have lab space focused on research and development work related “nutribiosis” or the interaction of nutrition, the microbiome and the functioning of the gut and immune system.
However, the company is not alone in this regard. Cargill also has been investing in ways to support gut health in young animals while reducing or eliminating the use of antibiotics.
The agri-giant recently started a group focused around work with health and technology on the understanding that addressing gut health is a way to support disease prevention.